Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer Journal Article
| Authors: | Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C. C.; Dantis, L.; Sklarin, N. T.; Seidman, A. D.; Hudis, C. A.; Moore, J.; Rosen, P. P.; Twaddell, T.; Henderson, I. C.; Norton, L. |
| Article Title: | Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer |
| Keywords: | carcinoma cells; ovarian-cancer; monoclonal-antibodies; c-erbb-2; neu oncogene; proto-oncogene; extracellular domain; tyrosine kinase-activity; tumor-cell lines; cis-diamminedichloroplatinum |
| Journal Title: | Seminars in Oncology |
| Volume: | 26 |
| Issue: | 4 Suppl. 12 |
| ISSN: | 0093-7754 |
| Publisher: | Elsevier Inc. |
| Date Published: | 1999-08-01 |
| Start Page: | 78 |
| End Page: | 83 |
| Language: | English |
| ACCESSION: | WOS:000082526300009 |
| PROVIDER: | wos |
| PUBMED: | 10482197 |
| Notes: | Article; Proceedings Paper -- Medical Oncologist Consensus Conference on the Future Directions with Herceptin (Trastuzumab) for Breast Cancer -- JUL 16-18, 1998 -- MAUI, HAWAII -- 12 -- Source: Wos |
